Company Summary
Search
Home Page
 
Sernova Corp. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
October 31TradingN
Board of Directors
NamePosition
Devinder (Dev) Randhawa  Director of the Board
Eldon R Smith  Director of the Board
Frank Holler  Director of the Board
George Adams  Chairperson of the Board
  Director of the Board
Jeffrey A. Bacha  Director of the Board
Justin Leushner  Director of the Board
Philip Toleikis  Director of the Board
  President
William A. Cochrane  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
19/Aug/1998  Canada British Columbia  
Exchange Filing Office
Location
Vancouver Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research And Development In The Life Sciences  About Sernova (From News Release January 31, 2014) Sernova Corp is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch?, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cells) which then release proteins and/or hormones as required. The therapeutic cells are protected from immune attack by Sernova's proprietary technology, Sertolin?.  
Securities
SymbolSecurity NameMarketStatus
SVASernova Corp.TSX VentureTRADING
Name HistoryFromTo
Sernova Corp.20/Sep/2006Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFRNot Received
Associations
Auditing Firm:  Davidson & Company LLP
Subsidiary:  Sertocell Biotechnology (US) Corp.
Transfer Agent:  CST Trust Company
Latest Information
TypeDateTitle
News Releases  22/Apr/2014  NEWS RELEASE - SERNOVA'S CELL POUCH(TM) DIABETES CLINICAL TRIAL DEMONSTRATES INTERIM SAFETY AND BIOCOMPATIBILITY[MARKETWIRE]
    NEWS RELEASE - CELL POUCH(TM) DIABETES CLINICAL TRIAL DEMONSTRA[MARKET NEWS]
    NEWS RELEASE - SERNOVA ANNOUNCES ANNUAL MEETING RECORD DATE AND ADOPTS ADVANCE NOTICE BY-LAW[MARKETWIRE]
Bulletins  22/Mar/2013  Amendment
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data